These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 1929205)

  • 1. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
    Deshmukh A; Scott JA; Palmer EL; Hochberg FH; Gruber M; Fischman AJ
    Clin Nucl Med; 1996 Sep; 21(9):720-5. PubMed ID: 8879874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
    Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC
    J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
    Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
    Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
    Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
    J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
    Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
    Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
    Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
    Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
    J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
    Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
    Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
    Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC
    J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.
    Di Chiro G; Oldfield E; Wright DC; De Michele D; Katz DA; Patronas NJ; Doppman JL; Larson SM; Ito M; Kufta CV
    AJR Am J Roentgenol; 1988 Jan; 150(1):189-97. PubMed ID: 3257119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.